Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Breakaway issues updated research

18 Nov 2013 12:01

RNS Number : 2916T
Wolf Minerals Limited
18 November 2013
 



Breakaway issues updated research on Wolf Minerals

 

 

Breakaway Research recently released an updated commissioned research report covering Wolf Minerals Limited (ASX: WLF) (AIM: WLFE). To view a copy of the report, please visit our website at www.wolfminerals.com.au.

Breakaway Research is an independent research company. It is a member of the Breakaway Investment Group - an Australian financial services company that specialises in the resource sector; providing funds management, equity research and corporate advisory services.

 

ENDS

For further details, please contact:

 

Wolf Minerals Limited

Russell Clark

+61 8 6364 3776

Investec

Chris Sim/George Price

+44 20 7597 5970

 

Newgate Threadneedle

Graham Herring

+44 (0) 20 7653 9850

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABPBBTMBABBRJ
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSQuarterly Activities Report
28th Apr 20177:00 amRNSAppendix 5B
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.